RecruitingNot ApplicableNCT07588295

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease: the LAST-COP Study


Sponsor

Maria Cecilia Hospital

Enrollment

60 participants

Start Date

Mar 18, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Numerous clinical studies have highlighted the role of macrophages in the destabilization of coronary lesions; however, there is limited literature on the relationship between circulating monocytes and intraplaque macrophages. This study aims to evaluate and compare the presence of macrophages and their subsequent activation within coronary and peripheral atherosclerotic lesions, and to correlate these findings with the distribution of circulating monocyte subpopulations.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Optical Coherence Tomography assessment for people with acute coronary syndromes, critical limb ischemia, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTOptical Coherence Tomography assessment

assessment of the number of infiltrating macrophages


Locations(1)

Maria Cecilia Hospital

Cotignola, Ravenna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07588295


Related Trials